CD56 marks human dendritic cell subsets with cytotoxic potential

Oncoimmunology. 2013 Feb 1;2(2):e23037. doi: 10.4161/onci.23037.

Abstract

Human plasmacytoid and myeloid dendritic cells (DCs), when appropriately stimulated, can express the archetypal natural killer (NK)-cell surface marker CD56. In addition to classical DC functions, CD56+ DCs are endowed with an unconventional cytotoxic capacity.

Keywords: CD56; cytotoxicity; dendritic cells; human; myeloid DCs; plasmacytoid DCs.